Pascal Soriot, AstraZeneca CEO (Yang Guanyu/Xinhua via Getty Images)
April 25, 2024 07:16 AM EDT
People
Pharma

As­traZeneca’s Pas­cal So­ri­ot says new rise in pay is ‘re­al­ly about’ po­ten­tial suc­ces­sor

Ayisha Sharma

News Reporter

As­traZeneca CEO Pas­cal So­ri­ot vig­or­ous­ly de­fend­ed his re­cent­ly se­cured $23.5 mil­lion pay pack­age, cit­ing the UK phar­ma’s need to com­pete for tal­ent.

“It re­al­ly is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times